Browse 156 HPV clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
HPV is so common that most sexually active people get it at some point, and the body usually clears it without anyone knowing. When it lingers, certain types can cause cancer years later, including more than 90 percent of cervical cancers and most cancers of the throat. A vaccine that prevents these infections has been available since 2006. The vaccine does not treat an infection that is already there, and trials are testing therapeutic vaccines and treatments that clear HPV and precancer before it becomes cancer.
Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer
for
Cancer of the Head and Neck, Oropharynx Cancer,
Location: Columbia MO
Sponsor: University of Missouri-Columbia
Sex: All
Age: 18+
Code: NCT04444869
Phase 2, Recruiting
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
for
HPV-unrelated Head and Neck Squamous Cell Carcinoma
Location: St Louis MO, Fargo ND, Sioux Falls SD
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT04966481
Phase 3, Recruiting
Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)
for
Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma,
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 18+
Code: NCT06088381
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine
for
Human Papilloma Virus
Location: Denver CO
Sponsor: University of Colorado, Denver
Sex: All
Age: 18+
Code: NCT04611022
Recruiting
The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18+
Code: NCT01709448
Recruiting
Feasibility Trial of a Multi-level Media Production and Social Marketing Campaign to Reduce HPV Vaccine Hesitancy
for
Human Papillomavirus Infection, Vaccination Hesitancy
Location: Charlottesville VA
Sponsor: University of Virginia
Sex: All
Age: 18+
Code: NCT05860725
Recruiting
Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer
for
Head and Neck Cancer, Oropharynx Cancer, Human Papilloma Virus
Location: Montreal, London
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: All
Age: 18+
Code: NCT04178174
Phase 3, Recruiting
Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)
for
Oropharyngeal Cancer, HPV-Related Carcinoma
Location: Pittsburgh PA, Tampa FL, Omaha NE
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT06305676
Recruiting
Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer
for
Squamous Cell Carcinoma of the Head and Neck, Oropharynx,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT06223568
Phase 2, Recruiting
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)
for
Common Warts, Common Warts (Verruca Vulgaris),
Location: Brighton MA, West Palm Beach FL, Sweetwater FL,
Sponsor: Verrica Pharmaceuticals Inc.
Sex: All
Age: 2+
Code: NCT07637734
Phase 3, Recruiting
A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)
for
Human Papilloma Virus (HPV),
Location: Little Rock AR, Layton UT, Phoenix AZ, Seattle WA
Sponsor: Daré Bioscience, Inc.
Sex: Female
Age: 22 - 50
Code: NCT07601074
Phase 2, Recruiting
Zopa Retreatment and Vector Shedding in Adults With RRP